Extracorporeal Photopheresis for Acute Graft Versus Host Disease
Extracorporeal Photopheresis for Steroid-refractory Acute GVHD in Children and Young Adults: a Safety and Feasibility Study.
Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago
Listed as NCT00179855, this PHASE2/PHASE3 trial focuses on Cancer and Graft Versus Host Disease and remains completed. Sponsored by Ann & Robert H Lurie Children's Hospital of Chicago, it has been updated 7 times since 2003, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
7 versions recorded-
Mar 2025 — Present [monthly]
Completed PHASE2/PHASE3
Status: Unknown → Completed
-
Sep 2024 — Mar 2025 [monthly]
Unknown PHASE2/PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE2/PHASE3
Status: Unknown Status → Unknown · Phase: PHASE2_PHASE3 → PHASE2/PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE2_PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status PHASE2_PHASE3
▶ Show 2 earlier versions
-
Feb 2017 — Jun 2018 [monthly]
Unknown Status PHASE2_PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Unknown Status PHASE2_PHASE3
First recorded
Jul 2003
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Ann & Robert H Lurie Children's Hospital of Chicago
For direct contact, visit the study record on ClinicalTrials.gov .